139 related articles for article (PubMed ID: 31191821)
1. IgG based immunome analyses of breast cancer patients reveal underlying signaling pathways.
Gyurján I; Rosskopf S; Coronell JAL; Muhr D; Singer C; Weinhäusel A
Oncotarget; 2019 May; 10(37):3491-3505. PubMed ID: 31191821
[No Abstract] [Full Text] [Related]
2. The prostate cancer immunome: In silico functional analysis of antigenic proteins from microarray profiling with IgG.
Luna-Coronell JA; Vierlinger K; Gamperl M; Hofbauer J; Berger I; Weinhäusel A
Proteomics; 2016 Apr; 16(8):1204-14. PubMed ID: 27089054
[TBL] [Abstract][Full Text] [Related]
3. The Immunome of Colon Cancer: Functional In Silico Analysis of Antigenic Proteins Deduced from IgG Microarray Profiling.
Luna Coronell JA; Sergelen K; Hofer P; Gyurján I; Brezina S; Hettegger P; Leeb G; Mach K; Gsur A; Weinhäusel A
Genomics Proteomics Bioinformatics; 2018 Feb; 16(1):73-84. PubMed ID: 29505855
[TBL] [Abstract][Full Text] [Related]
4. Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation.
Velloso FJ; Campos AR; Sogayar MC; Correa RG
BMC Genomics; 2019 Feb; 20(1):152. PubMed ID: 30791886
[TBL] [Abstract][Full Text] [Related]
5. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
Sørlie T; Wang Y; Xiao C; Johnsen H; Naume B; Samaha RR; Børresen-Dale AL
BMC Genomics; 2006 May; 7():127. PubMed ID: 16729877
[TBL] [Abstract][Full Text] [Related]
6. Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer.
Pierobon M; Ramos C; Wong S; Hodge KA; Aldrich J; Byron S; Anthony SP; Robert NJ; Northfelt DW; Jahanzeb M; Vocila L; Wulfkuhle J; Gambara G; Gallagher RI; Dunetz B; Hoke N; Dong T; Craig DW; Cristofanilli M; Leyland-Jones B; Liotta LA; O'Shaughnessy JA; Carpten JD; Petricoin EF
Clin Cancer Res; 2017 Aug; 23(16):4919-4928. PubMed ID: 28446508
[No Abstract] [Full Text] [Related]
7. The Clinicopathological Significance and Correlative Signaling Pathways of an Autophagy-Related Gene, Ambra1, in Breast Cancer: a Study of 25 Microarray RNA-Seq Datasets and in-House Gene Silencing.
He RQ; Xiong DD; Ma J; Hu XH; Chen G; Sun WL
Cell Physiol Biochem; 2018; 51(3):1027-1040. PubMed ID: 30476925
[TBL] [Abstract][Full Text] [Related]
8. Denoising perturbation signatures reveal an actionable AKT-signaling gene module underlying a poor clinical outcome in endocrine-treated ER+ breast cancer.
Teschendorff AE; Li L; Yang Z
Genome Biol; 2015 Apr; 16(1):61. PubMed ID: 25886003
[TBL] [Abstract][Full Text] [Related]
9. Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression.
Scanlan MJ; Gout I; Gordon CM; Williamson B; Stockert E; Gure AO; Jäger D; Chen YT; Mackay A; O'Hare MJ; Old LJ
Cancer Immun; 2001 Mar; 1():4. PubMed ID: 12747765
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.
Merdad A; Karim S; Schulten HJ; Dallol A; Buhmeida A; Al-Thubaity F; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
Anticancer Res; 2014 Mar; 34(3):1355-66. PubMed ID: 24596383
[TBL] [Abstract][Full Text] [Related]
11. In-depth characterization of breast cancer tumor-promoting cell transcriptome by RNA sequencing and microarrays.
Callari M; Guffanti A; Soldà G; Merlino G; Fina E; Brini E; Moles A; Cappelletti V; Daidone MG
Oncotarget; 2016 Jan; 7(1):976-94. PubMed ID: 26556871
[TBL] [Abstract][Full Text] [Related]
12. Alcohol consumption and breast tumor gene expression.
Wang J; Heng YJ; Eliassen AH; Tamimi RM; Hazra A; Carey VJ; Ambrosone CB; de Andrade VP; Brufsky A; Couch FJ; King TA; Modugno F; Vachon CM; Hunter DJ; Beck AH; Hankinson SE
Breast Cancer Res; 2017 Sep; 19(1):108. PubMed ID: 28899409
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of ductal carcinomas in situ and invasive breast tumors.
Seth A; Kitching R; Landberg G; Xu J; Zubovits J; Burger AM
Anticancer Res; 2003; 23(3A):2043-51. PubMed ID: 12894577
[TBL] [Abstract][Full Text] [Related]
14. Differential expression and clinical significance of glioblastoma mRNA expression profiles in Uyghur and Han patients in Xinjiang province.
Liu L; Li W; Xia H; Zhu Z; Luan X
Med Sci Monit; 2014 Nov; 20():2404-13. PubMed ID: 25418065
[TBL] [Abstract][Full Text] [Related]
15. Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma.
Agnihotri S; Gugel I; Remke M; Bornemann A; Pantazis G; Mack SC; Shih D; Singh SK; Sabha N; Taylor MD; Tatagiba M; Zadeh G; Krischek B
J Neurosurg; 2014 Dec; 121(6):1434-45. PubMed ID: 25245477
[TBL] [Abstract][Full Text] [Related]
16. Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival.
Tang W; Zhou M; Dorsey TH; Prieto DA; Wang XW; Ruppin E; Veenstra TD; Ambs S
Genome Med; 2018 Dec; 10(1):94. PubMed ID: 30501643
[TBL] [Abstract][Full Text] [Related]
17. Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA).
Hamrita B; Chahed K; Kabbage M; Guillier CL; Trimeche M; Chaïeb A; Chouchane L
Clin Chim Acta; 2008 Jul; 393(2):95-102. PubMed ID: 18424265
[TBL] [Abstract][Full Text] [Related]
18. A microRNA signature associated with pathological complete response to novel neoadjuvant therapy regimen in triple-negative breast cancer.
García-Vazquez R; Ruiz-García E; Meneses García A; Astudillo-de la Vega H; Lara-Medina F; Alvarado-Miranda A; Maldonado-Martínez H; González-Barrios JA; Campos-Parra AD; Rodríguez Cuevas S; Marchat LA; López-Camarillo C
Tumour Biol; 2017 Jun; 39(6):1010428317702899. PubMed ID: 28621239
[TBL] [Abstract][Full Text] [Related]
19. Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer.
Saini KS; Loi S; de Azambuja E; Metzger-Filho O; Saini ML; Ignatiadis M; Dancey JE; Piccart-Gebhart MJ
Cancer Treat Rev; 2013 Dec; 39(8):935-46. PubMed ID: 23643661
[TBL] [Abstract][Full Text] [Related]
20. Effective personalized therapy for breast cancer based on predictions of cell signaling pathway activation from gene expression analysis.
Jhan JR; Andrechek ER
Oncogene; 2017 Jun; 36(25):3553-3561. PubMed ID: 28135251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
